Redx Pharma PLC says that discussions about a potential takeover by Yesod Bio-Sciences have been terminated and the UK biotech has decided to stay independent after securing significant funding from two major investment houses.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?